Iterum Therapeutics Plc Stock Price, News & Analysis
Company Description
Iterum Therapeutics Plc (OTC Link: ITRMF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $2.7M.
ITRMF stock has gained 0.0% over the past year. Shares last traded at $0.0499.
On a trailing twelve-month basis, Iterum Therapeutics Plc reported net income of -$24.8M and diluted earnings per share of $-1.26.
This page provides a comprehensive overview of ITRMF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Iterum Therapeutics Plc (ITRMF) stock last traded at $0.0499. At a market capitalization of $2.7M, ITRMF is classified as a micro-cap stock with approximately 53.3M shares outstanding.
ITRMF Rankings
Latest News
SEC Filings
Iterum Therapeutics Plc has filed 1 recent SEC filing, including 1 Form 25-NSE. The most recent filing was submitted on June 23, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ITRMF SEC filings →
Financial Highlights
operating income reached -$18.7M, and net income was -$24.8M. Diluted earnings per share stood at $-1.26. The company generated -$26.8M in operating cash flow. With a current ratio of 1.41, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in Iterum Therapeutics Plc (ITRMF) currently stands at 1.1 million shares, representing 2.5% of the shares outstanding. Over the past 12 months, short interest has decreased by 35.4%. With 18.6 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Iterum Therapeutics Plc (ITRMF) currently stands at 18.6 days, up 392.1% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 1765% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 18.6 days.
ITRMF Company Profile & Sector Positioning
Iterum Therapeutics Plc (ITRMF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.